FDA Inspection 1045834 — Infacare Pharmaceutical Corporation

Infacare Pharmaceutical Corporation — FEI 3008606350

The FDA completed an inspection of Infacare Pharmaceutical Corporation on Mar 16, 2018 in Bedminster, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bedminster, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.